PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
07-Oct-2024 ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries ViiV Healthcare
07-Oct-2024 EVERSANA Expands Global Commercialisation Operations With Berlin, Germany Office EVERSANA
07-Oct-2024 Myricx Bio Announces Appointment of Paolo Paoletti MD as an Independent Non Executive Director Myricx Bio
07-Oct-2024 RoukenBio completes phase 2 discovery centre expansion and unveils new brand identity RoukenBio
07-Oct-2024 PulseSight Therapeutics to Present Data on PST-611 at EVER Congress 2024 PulseSight Therapeutics SAS
07-Oct-2024 Avillion announces positive high-level results from Phase III BATURA trial with AstraZeneca’s inhaled anti-inflammatory medication Airsupra in asthma patients Avillion and AstraZeneca
07-Oct-2024 Major Shareholder Announcement Genmab A/S
07-Oct-2024 Nouscom to Present Updated Positive Data on NOUS-209’s Potential to ‘Intercept’ Cancer in Lynch Syndrome Carriers at SITC 2024 Nouscom
07-Oct-2024 Researchers develop way to selectively target diseased cells in motor neurone disease The Francis Crick Institute
07-Oct-2024 Endoscopy Devices Market: The Impact of Technological Advancements Pristine Market Insights
04-Oct-2024 AI-Powered Protocol Generation: A New Era in Clinical Trials clinion
04-Oct-2024 Tower Launches Customer Sustainability Hub with Practical Tools for Lower-Impact Pharmaceutical Cold Chain Tower Cold Chain
03-Oct-2024 Coronado Research announce engagement of Rob Nichols to support the growth of their Clinical Technology Practice Coronado Research
03-Oct-2024 PHARMASEAL AND LEDGER RUN FORGE PARTNERSHIP TO ENHANCE CLINICAL BUSINESS OPERATIONS PHARMASEAL
03-Oct-2024 White City Place signs landmark tenant Imperial College London, continuing rapid growth as part of leading UK life sciences and technology district Stanhope
03-Oct-2024 Lundbeck initiates clinical trial in immunology for Lu AG22515 in Thyroid Eye Disease H. Lundbeck A/S
03-Oct-2024 ProductLife Group (PLG) Acquires Nextep to Further Expand its Global Patient Access Capabilities ProductLife Group
03-Oct-2024 MitoRx Therapeutics Strengthens Leadership with Key Appointments as it Reveals Obesity Programme MitoRx Therapeutics
03-Oct-2024 Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma Recursion
03-Oct-2024 European Commission approves Yuvanci® (Single Tablet Combination Therapy [STCT] of Macitentan and Tadalafil) for Treatment of Patients with Pulmonary Arterial Hypertension (PAH) Janssen-Cilag International NV